Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA: Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
The good news is most side effects improve with time, and simple strategies can make them easier to handle
Mulheres grvidas ou que amamentam tambm no devem consumir o suplemento
The relatively high systemic insulin levels counteract the lipolytic effects of the high GH levels in fat and muscle, but they do not reach adequate levels in the portal vein, so the liver remains under the control of GH, which still induces gluconeogenesis, increasing hyperglycemia [33]
The only difference appears months later when results don't replicate, when dose-response curves don't match prior studies, when peer reviewers question your data